Volume 44, Issue 6 pp. 1351-1360
REVIEW

Candidate Scaffolds for the Treatment of Stress Urinary Incontinence: A Narrative Review

Ilaha Isali

Corresponding Author

Ilaha Isali

Department of Urology, New York-Presbyterian/Weill Cornell Medicine, New York, New York, USA

Correspondence: Ilaha Isali ([email protected])

Search for more papers by this author
Narmina Khanmammadova

Narmina Khanmammadova

Department of Urology, University of California, Irvine, California, USA

Search for more papers by this author
Cosku Ozcelik

Cosku Ozcelik

School of Medicine, New York Medical College, Valhalla, New York, USA

Search for more papers by this author
Thomas R. Wong

Thomas R. Wong

Department of Urology, Case Western Reserve University, Cleveland, Ohio, USA

Search for more papers by this author
Daniel Shen

Daniel Shen

School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Search for more papers by this author
First published: 29 June 2025

ABSTRACT

Aims

Biodegradable scaffolds have emerged as a promising alternative to polypropylene (PP) meshes for the treatment of stress urinary incontinence (SUI) due to their biocompatibility and potential for tissue regeneration.

Methods

A narrative review was conducted focusing on articles published within the last 10 years.

Results

Polymeric materials such as small intestinal submucosa (SIS), poly(lactic acid) (PLA), poly(Chitosan-g-lactic Acid) (PCLA), poly(glycolic acid) (PGA), and poly(lactic-co-glycolic acid) (PLGA) have been explored for their ability to provide mechanical support, facilitate tissue repair, and degrade in a controlled manner. Each material offers unique advantages, such as SIS's enhanced biocompatibility, PLA's mechanical strength, and PGA's rapid degradation. However, challenges remain in optimizing these materials for clinical use, including controlling degradation rates, minimizing inflammatory responses, and addressing issues related to scaffolds' mechanical properties. Moreover, integrating adipose-derived stem cells (ADSCs) has shown promise in enhancing tissue regeneration and angiogenesis. The primary obstacles preventing clinical implementation have been premature scaffold degradation before adequate tissue ingrowth and insufficient tensile strength in dynamic pelvic environments.

Conclusions

This review discusses the current state of biodegradable scaffolds for SUI treatment, highlighting their potential benefits, ongoing challenges, and the need for further research to ensure their safety and efficacy in clinical applications.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The authors have nothing to report.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.